Click here to see the full list in PubMed:

Oncoimmunology. 2023, (in press) In vitro Vascular System Efficiently Natural Killer Cells for Cancer Immunotherapies.

International Journal of Molecular Sciences, 2022. ONC201-induced mitochondrial dysfunction, senescence-like phenotype and sensitization of cultured BT474 human breast cancer cells to TRAIL.

Journal of Hematology & Oncology, 2021. “NK cell-based cancer immunotherapy: from basic biology to clinical development”

Stem Cells, 2021. “Down–regulation of GLI1 expression in human pluripotent stem cells differentially affects lineage commitments”

Oncotarget, 2020. “Down Syndrome iPSC Model:  Endothelial Perspective on Tumor Development”

Scientific Reports, 2020. “iPSC–Derived progenitor stromal cells provide new insights into aberrant musculoskeletal development and resistance to cancer in Down syndrome”

Cell Signaling, 2020. Dephosphorylation of Fas-ligand and caveolin-1 is a prerequisite step in Fas-ligand - caveolin-1 complex formation and cell death stimulation

Stem Cell Reports, 2018. “Disruption of GRIN2B Impairs Differentiation in Human Neurons”

Experimental Hematology, 2018. “Application of Small Molecule CHIR99021 Leads to the Loss of Hemangioblast Progenitor and Increased Hematopoiesis of Human Pluripotent Stem Cells”

Cell Death & Disease, 2018. “Impairment of Fas-ligand-caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death

Nature Structural & Molecular Biology, 2017. “Chromatin-enriched lncRNAs can act as cell-type specific activators of proximal gene transcription”

Stem Cell Research & Therapy, 2017. “Cytokine Free Directed Differentiation of hPSC Efficiently Produces Hemogenic Endothelium with Lymphoid Potential”